Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06599736 · ClinicalTrials.gov registry record · NA

A Study of RhinAer Stylus for Treating Chronic Rhinitis

A NA study of Chronic Rhinitis, sponsored by Aerin Medical.

Active
Registry status
NA
Development phase
25
Enrollment target
2
Study locations

NCT06599736 is a NA study of Chronic Rhinitis that is active but no longer recruiting, run by Aerin Medical. The registered enrollment target is 25 participants, below the 93-participant average among 6 other Chronic Rhinitis trials with a reported enrollment target (73% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06599736, a NA study of Chronic Rhinitis, is active but no longer recruiting, sponsored by Aerin Medical.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
25 participants
Enrollment target
2
Study locations

Study Summary

Post-market study to continue to evaluate the effectiveness of the RhinAer Stylus for chronic rhinitis and the effect of treatment on inflammatory biomarkers.

Conditions Studied

Interventions

  • DEVICE RhinAer Stylus

Study Locations (2)

Colorado

  • Colorado ENT & Allergy - Colorado Springs

Ohio

  • University of Cincinnati - Cincinnati

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2024-10-03
Est. Completion 2026-03
Phase NA

Sponsor

Aerin Medical

14 total trials

What the Registry Record Tells You About NCT06599736

The ClinicalTrials.gov registry entry for NCT06599736 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 93-participant average among 6 other Chronic Rhinitis trials with a reported enrollment target (73% lower). The listed sponsor is Aerin Medical, which has 14 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Rhinitis appearing as the primary indexed condition, and to 1 intervention - of which RhinAer Stylus is the first listed.

NCT06599736 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Colorado, Ohio.

Frequently Asked Questions

What is clinical trial NCT06599736 about?

NCT06599736 is a clinical study titled "A Study of RhinAer Stylus for Treating Chronic Rhinitis". Post-market study to continue to evaluate the effectiveness of the RhinAer Stylus for chronic rhinitis and the effect of treatment on inflammatory biomarkers.

What is the current status of trial NCT06599736?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2024-10-03. Estimated completion is 2026-03.

What conditions does trial NCT06599736 study?

This clinical trial studies the following conditions: Chronic Rhinitis.

What interventions are being tested in trial NCT06599736?

The interventions under investigation include: RhinAer Stylus (DEVICE).

Who is sponsoring clinical trial NCT06599736?

This trial is sponsored by Aerin Medical, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06599736 being conducted?

This trial has 2 study locations across Colorado, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Rhinitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.